STOCK TITAN

RB Global Form 4 Filings

RBA NYSE

Every Form 4 that RB Global (RBA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RBA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RBA filings page.

Rhea-AI Summary

Morrison Gregory B reported acquisition or exercise transactions in this Form 4 filing.

RB Global Inc. director Gregory B. Morrison reported an award of 6 dividend equivalent rights tied to 2025 restricted share units on RBA common shares. These rights, which mirror the value of one common share each, brought his directly held dividend equivalent rights to 22, vesting in step with the related RSUs.

Rhea-AI Summary

RB Global Inc. director Elton Robert George reported awards of dividend equivalent rights tied to his existing deferred and restricted share units. On March 2, 2026, he acquired 96 dividend equivalent rights on deferred share units, 11 rights on 2024 RSUs, and 8 rights on 2025 RSUs, each representing the economic equivalent of one RBA common share and becoming exercisable in step with the underlying units.

Rhea-AI Summary

RB Global Inc. director Adam DeWitt reported the acquisition of additional equity-linked awards through dividend equivalents. On the reported date, he received 25 Dividend Equivalent Rights tied to deferred share units and 6 Dividend Equivalent Rights related to 2025 restricted share units, both at a price of $0.00 per right as grants or awards rather than open-market purchases. Following these transactions, his reported holdings increased to 555 Dividend Equivalent Rights tied to deferred share units and 22 Dividend Equivalent Rights tied to 2025 RSUs. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and vests or becomes exercisable alongside the underlying deferred share units or restricted share units.

Rhea-AI Summary

RB Global Inc. director Brian A. Bales reported acquiring additional derivative awards tied to company shares. On March 2, 2026, he received 7 Dividend Equivalent Rights related to deferred share units, 8 Dividend Equivalent Rights related to 2024 RSUs, and 6 Dividend Equivalent Rights related to 2025 RSUs, each at a price of $0.00 per right.

Each Dividend Equivalent Right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable concurrently or proportionately with the underlying deferred share units or restricted share units.

Rhea-AI Summary

RB Global Inc.’s Chief Legal Officer, Darren Jeffrey Watt, reported equity-based compensation awards tied to the company’s performance share plan. On February 12, 2026, he acquired 369 Dividend Equivalent Rights (2023 PSUs) and 10,976 Performance Share Units (2023 PSUs) as derivative securities at a price of $0 per unit.

Each PSU represents a contingent right to receive one RB Global common share or its economic equivalent, while each dividend equivalent right mirrors the value of one common share’s dividends. The PSUs are scheduled to vest on March 13, 2026, after performance criteria were determined to be satisfied, with underlying shares or cash to be delivered net of tax shortly after the vesting month ends.

Rhea-AI Summary

RB Global Inc. Chief Executive Officer James Francis Kessler reported an award of performance-based equity units tied to company shares. On 02/12/2026, he acquired 202,712 Performance Share Units (2023 PSUs) and 6,807 related Dividend Equivalent Rights at a price of $0 per unit.

The Compensation Committee determined that earlier performance criteria were satisfied, making these PSUs eligible for vesting. Each PSU and each dividend equivalent right represents a contingent right to receive one RB Global common share or its economic equivalent.

The PSUs are scheduled to vest on March 13, 2026. After vesting, the common shares or their cash value, net of tax, will be delivered to Kessler as soon as practicable following the end of that month.

Rhea-AI Summary

RB Global Inc. Chief Executive Officer James Francis Kessler reported an option exercise and share sale in the company’s common shares. On January 21, 2026, he exercised an Employee Stock Option covering 20,742 common shares at an exercise price of $80 per share, and on the same day sold 20,742 common shares at a price of $115 per share.

Following these transactions, Kessler directly held 107,569 common shares and indirectly held 1,854 common shares through an Employee Stock Purchase Plan, which includes all plan purchases through November 14, 2025. The reported option was originally granted on August 21, 2021, vested on August 12, 2024, and related to 20,742 underlying common shares.

Rhea-AI Summary

RB Global Inc. director Carol Melba Stephenson reported new derivative equity awards tied to the company’s common shares. On 12/17/2025, she received 13 dividend equivalent rights linked to deferred share units, 8 dividend equivalent rights related to 2024 restricted share units, and 6 dividend equivalent rights related to 2025 restricted share units, each at a price of $0.

Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable in line with the related deferred share units or restricted share units. Following these transactions, she beneficially owned 174, 57, and 16 derivative securities, respectively, all held directly.

Rhea-AI Summary

RB Global Inc. director Deborah Stein reported routine equity-related transactions involving dividend equivalent rights tied to her existing restricted share units. On December 17, 2025, she acquired dividend equivalent rights relating to the company’s 2024 and 2025 RSU grants. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share and becomes exercisable proportionately with the underlying RSUs.

Following these transactions, she held 57 derivative securities labeled as dividend equivalent rights related to 2024 RSUs and 16 related to 2025 RSUs, all at an exercise price of $0 and reported as directly owned. These updates reflect standard adjustments to maintain the value of prior equity awards when dividends are paid.

Rhea-AI Summary

RB Global Inc. director Timothy O'Day reported automatic grants of dividend equivalent rights tied to existing equity awards. On 12/17/2025, he acquired dividend equivalent rights relating to deferred share units and to restricted share units granted in 2024 and 2025. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share, generally becoming exercisable on the same schedule as the underlying deferred share units or restricted share units. These awards were reported as derivative securities with no exercise price, and no sales or disposals of RB Global equity were disclosed in this filing.

Rhea-AI Summary

RB Global Inc. director reports dividend-equivalent awards on Form 4. A board member of RB Global Inc. (RBA) disclosed three acquisitions of derivative securities on 12/17/2025, all at a price of $0. These are dividend equivalent rights tied to existing deferred share units and restricted share units, each representing the economic equivalent of one common share.

The director acquired 102 dividend equivalent rights related to deferred share units, bringing total beneficial ownership of these derivative securities to 4,566 held directly. In addition, the director acquired 10 dividend equivalent rights linked to a 2024 restricted share unit grant, for a total of 72, and 7 similar rights linked to a 2025 restricted share unit grant, for a total of 20. These rights become exercisable and payable in line with the underlying deferred or restricted share units.

Rhea-AI Summary

RB Global Inc. director reported routine equity-related transactions involving dividend equivalent rights tied to existing awards. On 12/17/2025, the reporting person acquired 7 dividend equivalent rights related to deferred share units, 8 rights related to 2024 restricted share units, and 6 rights related to 2025 restricted share units, all at a price of $0 per right.

Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable and payable in step with the underlying deferred share units or restricted share units.

Rhea-AI Summary

RB Global Inc. reported an insider equity compensation change for its Chief People Officer, Jennifer Laura Schmit, via a Form 4. On 12/17/2025, she acquired dividend equivalent rights linked to past restricted share unit (RSU) grants. These include 6 dividend equivalent rights tied to the 2024 RSU grant and 5 dividend equivalent rights tied to the 2025 RSU grant, each representing the economic equivalent of one RBA common share at an exercise price of $0. The rights become exercisable proportionately with the underlying RSUs. Following the transactions, she beneficially owned 24 derivative securities related to the 2024 RSUs and 14 related to the 2025 RSUs, all held directly.

Rhea-AI Summary

RB Global Inc. reported an insider equity update for its Chief Accounting Officer, Christopher Carlson. On December 17, 2025, Carlson received additional dividend equivalent rights linked to previously granted restricted share units (RSUs).

The filing shows awards of dividend equivalent rights that correspond to 4 common shares tied to 2023 RSUs, 7 common shares tied to 2024 RSUs, and 3 common shares tied to 2025 RSUs. These instruments carry an exercise price of $0 and represent the economic equivalent of one RB Global common share each.

After these transactions, Carlson beneficially owned 40 such derivative rights related to the 2023 RSUs, 61 related to the 2024 RSUs, and 9 related to the 2025 RSUs, all held directly. The dividend equivalent rights become exercisable proportionately with the underlying RSUs.

Rhea-AI Summary

RB Global Inc. reported an insider equity-related transaction by its Chief Legal Officer, who filed individually. On 12/17/2025, the officer acquired dividend equivalent rights tied to prior restricted share unit (RSU) grants. These derivative securities give a contingent right to receive the economic equivalent of one RB Global common share for each right.

The officer received 3 dividend equivalent rights related to 2023 RSUs, 4 related to 2024 RSUs, and 5 related to 2025 RSUs, all at an exercise price of $0 and coded as acquisitions. Following these transactions, the officer beneficially owned 31, 30, and 15 derivative securities for the 2023, 2024, and 2025 RSU-linked rights, respectively. These rights become exercisable proportionately with the underlying RSUs.

Rhea-AI Summary

RB Global Inc. officer and Chief Operations Officer reported new derivative awards tied to existing restricted share units. On 12/17/2025, the insider acquired 22 dividend equivalent rights linked to the 2024 RSU grant and 13 dividend equivalent rights linked to the 2025 RSU grant, each at a price of $0. Each dividend equivalent right represents the economic equivalent of one RBA common share and becomes exercisable proportionately with the related RSUs. Following these transactions, the insider held 106 dividend equivalent rights related to 2024 RSUs and 36 related to 2025 RSUs, all owned directly.

Rhea-AI Summary

RB Global Inc. chief financial officer reports dividend equivalent rights tied to RSUs. On December 17, 2025, the company’s CFO, identified as the reporting person on this Form 4, acquired additional derivative securities in the form of dividend equivalent rights linked to prior restricted share unit grants. These include 37 dividend equivalent rights related to the 2024 RSU grant and 28 dividend equivalent rights related to the 2025 RSU grant, each representing the economic equivalent of one RB Global common share with an exercise price of $0. Following these transactions, the reporting person beneficially owned 262 dividend equivalent rights associated with the 2024 RSUs and 111 dividend equivalent rights associated with the 2025 RSUs, all held directly.

Rhea-AI Summary

RB Global Inc. reported an insider equity compensation update for its Chief Executive Officer, James F. Kessler. On 12/17/2025, Kessler received new derivative awards in the form of dividend equivalent rights tied to prior restricted share unit (RSU) grants. These awards cover 52 rights related to 2023 RSUs, 79 rights related to 2024 RSUs, and 139 rights related to 2025 RSUs, each at a price of $0.

Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable proportionately with the underlying RSUs. Following these grants, Kessler beneficially owns 568, 561, and 391 dividend equivalent rights associated with the 2023, 2024, and 2025 RSU awards, respectively, reflecting standard equity-based compensation rather than open-market share purchases.

Rhea-AI Summary

RB Global Inc. director Michael D. Sieger reported routine equity-related transactions involving derivative securities tied to the company’s common shares. On 12/17/2025, he acquired 52 dividend equivalent rights related to his deferred share units and 6 dividend equivalent rights related to his 2025 restricted share units, each at a price of $0. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable in line with the underlying deferred share units or restricted share units. Following these transactions, he held 59 dividend equivalent rights linked to deferred share units and 16 linked to 2025 restricted share units in direct ownership.

Rhea-AI Summary

RB Global Inc. director reports new dividend equivalent rights

A director of RB Global Inc. reported routine equity-based compensation activity dated 12/17/2025. The filing shows the acquisition of 61 dividend equivalent rights tied to deferred share units, each representing the economic equivalent of one RB Global common share and becoming exercisable and payable at the same time as the deferred share units. Following this transaction, the director holds 1,965 of these derivative securities.

The director also acquired 6 dividend equivalent rights related to the 2025 restricted share unit (RSU) grant, each again linked one-for-one to RB Global common shares and becoming exercisable in proportion to the underlying RSUs. After this transaction, the director holds 16 such RSU-related dividend equivalent rights. All of these awards were reported at an exercise price of $0, reflecting their nature as equity incentives rather than open-market purchases.

Rhea-AI Summary

RB Global Inc. director Gregory B. Morrison reported a small equity-related award in the form of derivative securities. On 12/17/2025, he acquired 6 dividend equivalent rights linked to the company’s 2025 grant of restricted share units (RSUs). Each dividend equivalent right entitles him to receive the economic value of one RB Global common share, and these rights become exercisable in step with the related 2025 RSUs.

Following this transaction, Morrison beneficially owned 16 derivative securities of this type, all held in direct ownership. The derivative securities have an exercise price of $0, underscoring that this is an equity-based compensation feature rather than a market purchase.

Rhea-AI Summary

RB Global Inc. director Adam DeWitt reported derivative equity awards tied to the company’s common shares. On 12/17/2025, he acquired 27 Dividend Equivalent Rights (DSUs) related to deferred share units and 6 Dividend Equivalent Rights related to his 2025 restricted share units (RSUs), each at a price of $0.

Each dividend equivalent right is a contingent right to receive the economic equivalent of one RB Global common share. The DSU-related rights become exercisable and payable concurrently with the deferred share units, while the RSU-related rights become exercisable proportionately with the associated 2025 RSU grant.

Rhea-AI Summary

RB Global Inc. insider filing: Chief Technology Officer Nancy Elizabeth King filed a Form 4 related to RB Global Inc. (RBA), with an earliest reported transaction date of 11/20/2025. The excerpt identifies her role and confirms the filing is made by a single reporting person, but does not show specific share amounts or transaction details.

Rhea-AI Summary

RB Global (RBA) disclosed an insider share purchase by a director. On 11/13/2025, the reporting person acquired 1,000 common shares at a price of $101.258 per share, coded as a purchase (P).

Following this transaction, the reporting person beneficially owns 1,000 shares, held directly.

Rhea-AI Summary

Insider acquisition recorded on Form 4 for RB GLOBAL INC. (RBA). On 09/18/2025, reporting person Elton Robert George received dividend equivalent rights tied to deferred share units and restricted share units. The filing shows 87 dividend equivalent rights related to deferred share units, 9 related to 2024 RSUs, and 6 related to 2025 RSUs, each representing a contingent right to the economic equivalent of one common share. After these accruals, the amounts reported as beneficially owned following the transactions were 4,464, 62, and 13 common shares respectively, held directly. The dividend equivalents become exercisable and payable concurrently with the underlying deferred share units or proportionately with the related RSUs.

Rhea-AI Summary

Timothy J. O'Day, a director of RB Global Inc. (RBA), reported acquisitions on a Form 4 dated 09/18/2025 of dividend equivalent rights tied to deferred share units and restricted share units. The filing shows acquisitions of 6, 7, and 5 dividend equivalent rights (all exercisable or payable with the related underlying awards) with a reported price of $0. The entries reflect derivative reporting lines for dividend equivalents related to DSUs and 2024 and 2025 RSU grants, and the beneficial ownership following the transactions is shown as 52, 49, and 10 shares respectively. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Deborah Stein, a director of RB Global Inc. (Ticker: RBA), reported acquisitions on a Form 4 dated 09/18/2025. The filing shows she received 7 dividend equivalent rights related to the 2024 restricted share unit (RSU) grant and 5 dividend equivalent rights related to the 2025 RSU grant. Each dividend equivalent right represents the economic equivalent of one common share and becomes exercisable proportionately with the underlying RSUs. The Form 4 lists the underlying titles as Common Shares, with post-transaction beneficial ownership figures shown as 49 and 10 shares for the respective grant-related rights. The transactions were reported as acquisitions (code A) with no cash price reported.

Rhea-AI Summary

Carol Melba Stephenson, a director of RB Global Inc. (RBA), reported acquisitions of dividend equivalent rights tied to deferred share units and restricted share units on 09/18/2025. The Form 4 shows three separate accruals: 11 dividend equivalent rights from deferred share units (bringing that holding to 161 common-share equivalents), 7 from 2024 RSUs (holding to 49), and 5 from 2025 RSUs (holding to 10). Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share and becomes exercisable or payable concurrently with the related units. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Brian A. Bales, a director of RB Global Inc. (RBA), reported acquisitions on 09/18/2025 of dividend equivalent rights tied to deferred share units and restricted share units. The filing lists three entries: 6 dividend equivalent rights (resulting beneficial ownership shown as 52), 7 dividend equivalent rights (beneficial ownership shown as 49) and 5 dividend equivalent rights (beneficial ownership shown as 10). Each dividend equivalent right represents a contingent entitlement to the economic equivalent of one RBA common share and becomes payable or exercisable concurrently with the underlying DSUs or proportionately with the related RSUs. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Michael Thomas Steven Lewis, Chief Operations Officer of RB Global, Inc. (RBA), reported acquisitions on 09/18/2025 of dividend equivalent rights tied to restricted share unit (RSU) grants. Nineteen dividend equivalent rights accrued for the 2024 RSU grant and eleven dividend equivalent rights accrued for the 2025 RSU grant; each right represents a contingent entitlement to the economic equivalent of one RBA common share and vests proportionately with the underlying RSUs. Following these reported transactions the filing shows 84 and 23 dividend-equivalent positions, respectively, held in a direct ownership form. The transactions were signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Insider Form 4 summary for RB Global Inc. (RBA)

Christopher Carlson, Chief Accounting Officer, reported acquisitions of dividend equivalent rights tied to restricted share unit grants. On 09/18/2025 he acquired 3 dividend equivalent rights related to 2023 RSUs, 6 related to 2024 RSUs, and 3 related to 2025 RSUs, representing the contingent economic equivalent of the indicated number of RBA common shares. After these transactions he beneficially owns 36, 54, and 6 shares attributable to each respective grant, reported as direct ownership. The form was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Jennifer Laura Schmit, Chief People Officer of RB Global Inc. (RBA), reported acquisition of dividend equivalent rights tied to restricted stock unit grants on 09/18/2025. She received 6 dividend equivalent rights related to the 2024 RSU grant and 4 dividend equivalent rights related to the 2025 RSU grant. Each dividend equivalent right represents the economic equivalent of one RBA common share and vests proportionately with the underlying RSUs. After these accruals, the filing shows beneficial ownership of 18 common shares attributable to the 2024-linked rights and 9 common shares attributable to the 2025-linked rights. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Schmit on 09/22/2025.

Rhea-AI Summary

James F. Kessler, Chief Executive Officer and director of RB Global Inc. (RBA), reported the receipt of additional dividend equivalent rights tied to restricted share unit grants. The Form 4 discloses acquisitions on 09/18/2025 of 46 dividend equivalent rights related to 2023 RSUs, 70 related to 2024 RSUs and 123 related to 2025 RSUs; each right represents the economic equivalent of one RBA common share and becomes exercisable with the underlying RSUs. The reported rights carry a $0 price and are held in a direct ownership form. The filing was signed by an attorney-in-fact for Mr. Kessler.

Rhea-AI Summary

Reported insider grant of dividend equivalent rights tied to RSUs. Darren Jeffrey Watt, identified as Chief Legal Officer and director of RB Global Inc. (RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights that represent the economic equivalent of common shares and accrue with restricted share units (RSUs). The filing shows 2 dividend equivalent rights from the 2023 RSU grant, 4 from the 2024 grant and 5 from the 2025 grant, with zero cash price reported. The filing lists the number of underlying common shares beneficially owned following the transactions as 28, 26 and 10 respectively. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Eric Guerin, Chief Financial Officer of RB Global Inc. (RBA), reported receipt of dividend equivalent rights tied to previously granted restricted share units. The Form 4 discloses two accruals dated 09/18/2025: 32 dividend equivalent rights related to the 2024 RSU grant and 57 dividend equivalent rights related to the 2025 RSU grant. Each dividend equivalent right represents a contingent economic entitlement equal to one RBA common share and becomes exercisable proportionately with the underlying RSUs.

The filing shows the ownership form as direct for both items and lists the amounts of common shares beneficially owned following the transactions as 225 and 83 respectively. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Guerin on 09/22/2025.

Rhea-AI Summary

Nancy Elizabeth King, Chief Technology Officer of RB Global Inc. (RBA), reported accrual and receipt of dividend equivalent rights tied to restricted share unit (RSU) grants. On 09/18/2025 she received 19 dividend equivalent rights related to 2024 RSUs and 13 dividend equivalent rights related to 2025 RSUs, representing the economic equivalent of that many RBA common shares. Following these accruals she beneficially owns 109 shares (associated with the 2024 grant) and 26 shares (associated with the 2025 grant), all held directly. The Form 4 was signed by an attorney-in-fact on 09/22/2025.

Rhea-AI Summary

Michael D. Sieger, a director of RB Global Inc. (ticker: RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights tied to deferred share units and to a 2025 restricted share unit (RSU) grant. The filing records an acquisition of 6 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to 2025 RSUs; each right represents a contingent entitlement to the economic equivalent of one RBA common share and were acquired at a price of $0. The reported ownership form for both items is direct. The form shows 52 and 10 derivative securities beneficially owned following the respective transactions. The filing was signed by an attorney-in-fact on behalf of Mr. Sieger on 09/19/2025.

Rhea-AI Summary

Sarah E. Raiss, a director of RB Global, Inc. (RBA), reported acquisition of dividend equivalent rights linked to deferred share units and restricted share units. On 09/18/2025 the filing shows the reporting person received 52 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to a 2025 restricted share unit grant. Each dividend equivalent right represents a contingent entitlement to the economic equivalent of one RBA common share and becomes exercisable and payable with the underlying units. After these accruals the report lists 1,904 common shares beneficially owned associated with the deferred share units and 10 common shares beneficially owned associated with the 2025 RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.

Rhea-AI Summary

RB Global Inc. (RBA) Form 4 shows Director Gregory B. Morrison was allocated 5 dividend equivalent rights tied to the 2025 restricted share unit (RSU) grant, each representing the economic equivalent of one common share. The transaction date is 09/18/2025 and the filing indicates 10 shares beneficially owned following the reported transaction, held directly. The filing was signed by an attorney-in-fact on behalf of Mr. Morrison on 09/19/2025. The explanation clarifies the dividend equivalents accrue with the 2025 RSUs and vest proportionately with those RSUs.

Rhea-AI Summary

Adam DeWitt, a director of RB Global Inc. (RBA), received dividend equivalent rights on 09/18/2025 related to deferred share units and a 2025 RSU grant. The Form 4 reports the accrual and immediate acquisition of 23 dividend equivalent rights tied to deferred share units and 5 dividend equivalent rights tied to 2025 restricted share units; each right represents a contingent economic equivalent to one RBA common share and carries a $0 price. The filing shows the beneficial ownership following these transactions as 503 common shares (for the deferred share unit-related rights) and 10 common shares (for the 2025 RSU-related rights). The Form 4 was signed by an attorney-in-fact on 09/19/2025.

Rhea-AI Summary

RB Global Inc. (RBA) insider sale disclosed. Chief Operations Officer Michael Thomas Steven Lewis reported a sale of 2,151 common shares on 09/12/2025 at a price of $118.15 per share, leaving 0 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 09/15/2025.